Disclosure Of Entity's Operating Segments [Text Block]

Zealand Pharma - Filing #1350008

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of entity's operating segments [text block]	—		—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	342,788,000 DKK	—	—	—	—	—	—	103,986,000 DKK	—	—	—
Tax expense (income)	—	5,126,000 DKK	—	—	—	—	—	—	6,431,000 DKK	—	—	—
Profit (loss) before tax	—	708,865,000 DKK	—	—	—	—	—	—	972,041,000 DKK	—	—	—
Profit (loss) from continuing operations	—	703,739,000 DKK	—	—	—	—	—	—	965,610,000 DKK	—	—	—
Profit (loss)	- DKK	703,739,000 DKK	—	703,739,000 DKK	- DKK	- DKK	—	- DKK	1,202,135,000 DKK	- DKK	1,202,135,000 DKK	- DKK
Assets	—	—	1,979,993,000 DKK	—	—	—	1,539,806,000 DKK	—	—	—	—	—
Liabilities	—	—	387,154,000 DKK	—	—	—	723,895,000 DKK	—	—	—	—	—
Cash flows from (used in) operating activities	—	425,668,000 DKK	—	—	—	—	—	—	942,311,000 DKK	—	—	—
Cash flows from (used in) investing activities	—	1,094,033,000 DKK	—	—	—	—	—	—	281,259,000 DKK	—	—	—
Cash flows from (used in) financing activities	—	907,014,000 DKK	—	—	—	—	—	—	587,500,000 DKK	—	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]